Brand et al. recently assessed the anti-tumor activity of two peptide-guided fusion proteins (tTF-TAA and tTF-LTL) targeting a surface proteoglycan called NG2, exposed on angiogenic pericytes in lung adenocarcinoma xenografts. Here, RHOH is linked to neoplasm.